Bot Chart, page-1141

agreed 100%.......personally i should have taken some profit at 28c and will reflect upon my failure to do so as a lesson learnt.....
fundamentals are such that BOT is a must have for any investor of any means.
aside of the dermatology applications which are well and thoroughly researched on this great thread, I can’t help but arrive at the conclusion, that if the almost coincidental discovery, of a superbug eliminating application is as reliable as it appears, then ground breaking and revolutionary are terms which are not misplaced. As is the way of some enthusiastic posters to speak of trains leaving stations and fast cars with rocket ships, so it is that a few earnest investors feel compelled to describe a handful of Bio’s as the next CSL. I don’t think it’s to fantastical to put it out there that BOT along with one or two other Cannabinol coys could well establish ‘weed’ based treatments as appropriate and mightily effective for a whole host of ailments. Very CLSish imho